Killer dendritic cells: mechanisms of action and therapeutic implications for cancer - PubMed (original) (raw)
Review
Killer dendritic cells: mechanisms of action and therapeutic implications for cancer
A K Wesa et al. Cell Death Differ. 2008 Jan.
Abstract
Dendritic cells (DC) are essential for the development and regulation of adaptive host immune responses against tumors. DC are heterogeneous and comprised of diverse cellular subsets. They are best known for mediating a crucial role in the initiation of acquired immunity by serving as professional antigen presenting cells (APC) that take up antigens in their local microenvironment, which are then processed and presented to naïve T cells in the context of major histocompatibility complex (MHC) class I and II molecules. In addition to these functions, DC can modulate the types of T cell responses they generate, and can also influence the responses of innate effectors, such as NK cells. There is also now evidence that they may mediate a more primordial role as innate, effector cells that are tumoricidal. 'Killer' DC (KDC) may represent a true 'multi-tasking' cell type that can sequentially act as a 'hunter-gatherer' of antigens; as well as, an instructor, then enforcer/regulator, of antigen-specific anti-tumor T-cell responses in vivo. In this review, we will critically examine the published record regarding KDC, their mechanism(s) of action, and then consider the potential integration of KDC into novel immunotherapies for patients with cancer.
Similar articles
- The 'kiss of death' by dendritic cells to cancer cells.
Chan CW, Housseau F. Chan CW, et al. Cell Death Differ. 2008 Jan;15(1):58-69. doi: 10.1038/sj.cdd.4402235. Epub 2007 Oct 19. Cell Death Differ. 2008. PMID: 17948029 Review. - Killer dendritic cells and their potential role in immunotherapy.
Ullrich E, Chaput N, Zitvogel L. Ullrich E, et al. Horm Metab Res. 2008 Feb;40(2):75-81. doi: 10.1055/s-2007-1022554. Horm Metab Res. 2008. PMID: 18283624 Review. - [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C, Taieb J, Terme M, Maruyama K, Flament C, Angevin E, Zitvogel L. Borg C, et al. Bull Cancer. 2003 Aug-Sep;90(8-9):699-705. Bull Cancer. 2003. PMID: 14609759 Review. French. - Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N. Terunuma H, et al. Int Rev Immunol. 2008;27(3):93-110. doi: 10.1080/08830180801911743. Int Rev Immunol. 2008. PMID: 18437601 Review. - Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Fernandez NC, et al. Nat Med. 1999 Apr;5(4):405-11. doi: 10.1038/7403. Nat Med. 1999. PMID: 10202929
Cited by
- Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2pos Breast Cancer.
Showalter LE, Czerniecki BJ, Kodumudi K, Koski GK. Showalter LE, et al. Vaccines (Basel). 2021 Sep 18;9(9):1037. doi: 10.3390/vaccines9091037. Vaccines (Basel). 2021. PMID: 34579275 Free PMC article. - Agonist antibody that induces human malignant cells to kill one another.
Yea K, Zhang H, Xie J, Jones TM, Lin CW, Francesconi W, Berton F, Fallahi M, Sauer K, Lerner RA. Yea K, et al. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):E6158-65. doi: 10.1073/pnas.1519079112. Epub 2015 Oct 20. Proc Natl Acad Sci U S A. 2015. PMID: 26487683 Free PMC article. - HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
Van den Bergh JM, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, Vorsters A, Van Tendeloo VF, Anguille S, Van Damme P, Smits EL. Van den Bergh JM, et al. J Cell Mol Med. 2014 Jul;18(7):1372-80. doi: 10.1111/jcmm.12284. Epub 2014 Jun 30. J Cell Mol Med. 2014. PMID: 24979331 Free PMC article. - PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.
Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. Hanke NT, et al. Eur J Immunol. 2014 Aug;44(8):2489-2499. doi: 10.1002/eji.201343803. Epub 2014 May 23. Eur J Immunol. 2014. PMID: 24777831 Free PMC article. - Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.
Hanke N, Alizadeh D, Katsanis E, Larmonier N. Hanke N, et al. Crit Rev Immunol. 2013;33(1):1-21. doi: 10.1615/critrevimmunol.2013006679. Crit Rev Immunol. 2013. PMID: 23510023 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials